{"url_path":"/sec/hrgn/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1563665/0001437749-26-016761-index.html","accession_number":"0001437749-26-016761","cik":"0001563665","ticker":"HRGN","issuer_name":"Harvard Apparatus Regenerative Technology, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1563665/0001437749-26-016761-index.html","primary_entity_key":"0001563665","primary_entity_name":"Harvard Apparatus Regenerative Technology, Inc."},"word_count":41,"has_tables":true,"body_markdown":"**Item 5. Other Information**\n\n \n\nDuring the *three* months ended *March 31, 2026*, no directors or officers adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-*1* trading arrangement,” as each term is defined in Item *408*(a) of Regulation S-K."}